Bank of America’s Arcadia Biosciences RKDA Stock Holding History
Bought
Maintained
Sold
Other funds holding RKDA
AC
SM
VCM
VFT
TRCT
SS
Bank of America's RKDA Position: Q1 2026 in Review
Bank of America sold out of Arcadia Biosciences (RKDA) in Q1 2026, closing a stake of 12 shares — an estimated $24 sold.
Bank of America first reported a position in RKDA in Q1 2016 and held it in 14 quarters. The position peaked at $9K in Q3 2016. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.
- Bank of America reported no remaining Arcadia Biosciences position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 12 Arcadia Biosciences shares in Q1 2026, an estimated $24.
- Bank of America first reported a position in Arcadia Biosciences in Q1 2016 and held it in 14 quarters.
- Bank of America's Arcadia Biosciences position peaked at $9K in Q3 2016.
- 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.